Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1980 Jan;44(1):34-7.

Treatment of chronic urticaria with an inhibitor of complement activation (cinnarizine)

K Kalimo, C T Jansen
  • PMID: 7352689
Clinical Trial

Treatment of chronic urticaria with an inhibitor of complement activation (cinnarizine)

K Kalimo et al. Ann Allergy. 1980 Jan.

Abstract

Twenty-three patients with chronic urticaria were treated with cinnarizine, dexchlorpheniramine and placebo in a double-blind, crossover trial. Compared to placebo treatment both cinnarizine and dexchlorpheniramine caused a statistically significant improvement in the clinical symptoms (p less than 0.01). The two active drugs were found to be equally effective; however, cinnarizine was better tolerated. Both drugs appear to be useful in the treatment of chronic urticaria.

PubMed Disclaimer

Publication types

LinkOut - more resources